Comparison of the effect of indacaterol versus salmeterol in patients with chronic obstructive pulmonary disease
Not Applicable
- Conditions
- Chronic obstructive pulmonary disease (COPD)
- Registration Number
- JPRN-UMIN000008384
- Lead Sponsor
- St. Marianna University School of Medicine, Respiratory and infectious diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients experienced acute exacerbation within 8 weeks before the start of this study. 2. Patients with an unstable cardiac diseases. 3. Patients deemed as inappropriate for this study by investigators.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The effects of indacaterol on FEV1 compared with other LABAs in patients with COPD
- Secondary Outcome Measures
Name Time Method